表紙
市場調査レポート

世界の馬の健康管理市場の予測

Global Equine Healthcare Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 323243
出版日 ページ情報 英文 90 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
世界の馬の健康管理市場の予測 Global Equine Healthcare Market 2015-2019
出版日: 2015年01月21日 ページ情報: 英文 90 Pages
概要

馬にとってのQOL(クオリティオブライフ)の改善、寿命の長期化、高品質の馬用フードの開発などを含む獣医学的部門を指す馬の健康管理市場は2014年から2019年にかけて1.24%のCAGRで推移すると予測されています。

当レポートでは、世界の馬の健康管理市場について調査し、市場の背景および概要、主要製品、製品区分(診断・治療・サプリメント・ワクチン)別の市場規模の推移と予測、地域別の動向、市場成長への各種影響因子の分析、競合環境、主要企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 製品区分別市場

  • 世界の馬の健康管理市場
    • 診断製品
    • 治療製品
    • サプリメント
  • 世界の馬ワクチン市場
    • 市場規模と予測

第8章 地域別市場

第9章 購入基準

第10章 市場成長因子

第11章 成長因子とその影響

第12章 市場の課題

第13章 成長因子と課題の影響

第14章 市場動向

第15章 動向とその影響

第16章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A

第17章 市場シェア分析

  • Affymetrix
  • Bayer Health Care
    • エンドユーザー別
  • Boehringer Ingelheim
  • Elanco
    • エンドユーザー別
    • 地域別
  • Merck Animal Health
    • エンドユーザー別区分
    • 地域別
  • Purina Animal
  • Zoetis
    • 種のタイプ別
    • 製品タイプ別
    • 地域別
    • 国別
    • エンドユーザー別
  • その他の有力ベンダー

第18章 主要ベンダーの分析

  • Affymetrix
  • Bayer HealthCare
  • Boehringer Ingelheim
  • Elanco Animal Health
  • Merck Animal Health
  • Purina
  • Zoetis
    • 主要データ
    • 事業概要
    • 部門別市場収益
    • 地域別市場収益
    • 事業戦略
    • 最近の発展動向
    • SWOT分析

第19章 関連レポート

図表一覧

目次
Product Code: IRTNTR5065

About Equine Healthcare

Equine health refers to veterinary services intended to treat horses to enhance their quality of life, increase their lifespan, and develop better quality animal food. Equine diagnostic products, equine therapeutic products, and equine supplement products are the three major product types discussed in this report. Equine diagnostic products help to detect bacteria, antibodies, and viruses; equine therapeutic products include vaccination that helps treat any disease condition; and equine supplement products help in maintaining specific requirement of supplements.

TechNavio's analysts forecast the Global Equine Healthcare market to decline at a CAGR of 1.24 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Equine Healthcare market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various equine healthcare products. In terms of product, the Global Equine Healthcare market can be divided into three segments: Equine Diagnostic Products, Equine Therapeutic Products, and Equine Genotype Analysis.

TechNavio's report, the Global Equine Healthcare Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Equine Healthcare market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Affymetrix
  • Bayer Health Care
  • Boehringer Ingelheim
  • Elanco Animal Health
  • Merck Animal Health
  • Purina Animal
  • Zoetis

Other Prominent Vendors

  • Boerhringer Ingelheim Vetmedica
  • Ceva Holdings
  • Merial
  • Novartis Animal Health
  • Signostics
  • Vetoquinol

Market Driver

  • Increase in Demand
  • For a full, detailed list, view our report

Market Challenge

  • Decrease in Global Equine Population
  • For a full, detailed list, view our report

Market Trend

  • Increase in Awareness
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Products

  • 07.1. Global Equine Vaccines Market
    • 07.1.1. Market Size and Forecast

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions

17. Market Share Analysis 2014

  • 17.1. Affymetrix
  • 17.2. Bayer Health Care
    • 17.2.1. Segmentation by End-user
  • 17.3. Boehringer Ingelheim
  • 17.4. Elanco
    • 17.4.1. Segmentation by End-user
    • 17.4.2. Segmentation by Geography
  • 17.5. Merck Animal Health
    • 17.5.1. Segmentation by End-user
    • 17.5.2. Segmentation by Geography
  • 17.6. Purina Animal
  • 17.7. Zoetis
    • 17.7.1. Segmentation by Species Type
    • 17.7.2. Segmentation by Product Type
    • 17.7.3. Segmentation by Geography
    • 17.7.4. Segmentation by Country
    • 17.7.5. Segmentation by End-user
  • 17.8. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Affymetrix
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation
    • 18.1.4. Business Segmentation by Revenue 2013
    • 18.1.5. Business Segmentation by Revenue 2012 and 2013
    • 18.1.6. Sales by Geography
    • 18.1.7. Business Strategy
    • 18.1.8. Key Information
    • 18.1.9. SWOT Analysis
  • 18.2. Bayer HealthCare
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation by Revenue 2013
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Geographical Segmentation by Revenue 2013
    • 18.2.6. Business Strategy
    • 18.2.7. Recent Developments
    • 18.2.8. SWOT Analysis
  • 18.3. Boehringer Ingelheim
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2013
    • 18.3.4. Business Segmentation by Revenue 2012 and 2013
    • 18.3.5. Geographical Segmentation by Revenue 2013
    • 18.3.6. Business Strategy
    • 18.3.7. Recent Developments
    • 18.3.8. SWOT Analysis
  • 18.4. Elanco Animal Health
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Strategy
    • 18.4.4. Recent Developments
    • 18.4.5. SWOT Analysis
  • 18.5. Merck Animal Health
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Business Strategy
    • 18.5.4. Recent Developments
    • 18.5.5. SWOT Analysis
  • 18.6. Purina
    • 18.6.1. Key Facts
    • 18.6.2. Business Overview
    • 18.6.3. Key Products
    • 18.6.4. Business Strategy
    • 18.6.5. Recent Developments
    • 18.6.6. SWOT Analysis
  • 18.7. Zoetis
    • 18.7.1. Key Facts
    • 18.7.2. Business Overview
    • 18.7.3. Business Segmentation by Revenue 2013
    • 18.7.4. Business Segmentation by Revenue 2012 and 2013
    • 18.7.5. Geographical Segmentation by Revenue 2013
    • 18.7.6. Business Strategy
    • 18.7.7. Recent Developments
    • 18.7.8. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Equine Healthcare Market 2014-2019 (US$ billion)
  • Exhibit 3: Global Equine Healthcare Market: Segmentation by Product
  • Exhibit 4: Global Equine Healthcare Market: Segmentation 2014
  • Exhibit 5: Global Equine Vaccines Market 2014-2019 (US$ billion)
  • Exhibit 6: Global Equine Healthcare Market by Geographical Segmentation 2014
  • Exhibit 7: Affymetrix Year on Year Sales Comparison 2010-2013 (US$ million)
  • Exhibit 8: Bayer's Revenue by Segment 2013
  • Exhibit 9: Bayer Animal Health: Segmentation by End-user
  • Exhibit 10: Eli Lilly: Revenue by Segment 2013
  • Exhibit 11: Elanco: Segmentation by End-user
  • Exhibit 12: Elanco: Revenue by Geography 2013
  • Exhibit 13: Merck: Revenue by Segment 2013
  • Exhibit 14: Merck Animal Health: Segmentation by End-user
  • Exhibit 15: Merck Animal Health: Segmentation by End-user
  • Exhibit 16: Merck Animal Health: Segmentation by Geography 2013
  • Exhibit 17: Land O Lakes Year on Year Sales Comparison 2010-2013 (US$ million)
  • Exhibit 18: Zoetis: Segmentation by Species Type
  • Exhibit 19: Zoetis: Revenue of Species Type Segmentation 2013
  • Exhibit 20: Zoetis: Segmentation by Product Type
  • Exhibit 21: Zoetis: Revenue of Product Type Segmentation 2013
  • Exhibit 22: Zoetis: Revenue of Geographical Segmentation 2013
  • Exhibit 23: Zoetis: Revenue Segmentation by Geography
  • Exhibit 24: Zoetis: Revenue of Country-wise Segmentation 2013
  • Exhibit 25: Zoetis: Segmentation by End-user
  • Exhibit 26: Zoetis: Revenue of End-user Segment 2013
  • Exhibit 27: Zoetis: Companion Animals Segmentation by Product Type
  • Exhibit 28: Zoetis: Companion Animals Segmentation by Species Type
  • Exhibit 29: Zoetis: Revenue of Companion Animals Segment by Species Type 2013
  • Exhibit 30: Zoetis: Revenue of Companion Animals Segment by Geography 2013
  • Exhibit 31: Affymetrix Inc.: Business Segmentation 2013
  • Exhibit 32: Affymetrix Inc.: Business Segmentation by Revenue 2013
  • Exhibit 33: Affymetrix Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 34: Affymetrix Inc.: Sales by Geography 2013
  • Exhibit 35: Bayer HealthCare: Business Segmentation by Revenue 2013
  • Exhibit 36: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 37: Bayer HealthCare: Geographical Segmentation by Revenue 2013
  • Exhibit 38: Boehringer Ingelheim: Business Segmentation by Revenue 2013
  • Exhibit 39: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 40: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
  • Exhibit 41: Purina: Key Products
  • Exhibit 42: Zoetis: Business Segmentation by Revenue 2013
  • Exhibit 43: Zoetis: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 44: Zoetis: Geographical Segmentation by Revenue 2013
Back to Top